Immediate Impact

1 by Nobel laureates 31 hit
Sub-graph 1 of 15

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Hit
The future of pharmaceuticals: Artificial intelligence in drug discovery and development
2025 Hit
2 intermediate papers

Works of Frederik Peters being referenced

Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data Analysis
2021
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations
2012

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Frederik Peters 414 317 159 103 92 66 820
John I. Mackowiak 170 0.4× 300 0.9× 100 0.6× 115 1.1× 9 0.1× 48 937
Oscar H. Grandas 191 0.5× 125 0.4× 125 0.8× 101 1.0× 28 0.3× 43 707
Lee Stern 119 0.3× 170 0.5× 78 0.5× 32 0.3× 12 0.1× 64 879
Y. Friedlander 116 0.3× 212 0.7× 66 0.4× 51 0.5× 49 0.5× 25 775
J.Conor O’Shea 445 1.1× 54 0.2× 747 4.7× 45 0.4× 29 0.3× 40 932
James N. Frame 160 0.4× 263 0.8× 40 0.3× 41 0.4× 22 0.2× 41 991
Macit Kalçık 296 0.7× 188 0.6× 714 4.5× 36 0.3× 18 0.2× 122 1.0k
Kai Gjerløff Schmidt 168 0.4× 120 0.4× 80 0.5× 91 0.9× 7 0.1× 37 1.0k
Jeffery B. Dattilo 474 1.1× 358 1.1× 208 1.3× 56 0.5× 45 0.5× 42 866
Justyna Bartoszko 123 0.3× 37 0.1× 86 0.5× 47 0.5× 39 0.4× 36 836

All Works

Loading papers...

Rankless by CCL
2026